hMTH1 (8-oxo-2′-deoxyguanine triphosphatase) hydrolyzes oxidized nucleoside triphosphates; its presence is non-essential for survival of normal cells but is required for survival of cancer cells. In this study, 8-halogenated-7-deaza-2′-deoxyguanosine triphosphate (8-halogenated-7-deazadGTP) derivatives were synthesized. Interestingly, these triphosphates were poor substrates for hMTH1, but exhibited strong competitive inhibition against hMTH1 at nanomolar levels. This inhibitory effect is attributed to slower rate of hydrolysis, possibly arising from enzyme structural changes, specifically different stacking interactions with 8-halogenated-7-deazadGTP. This is the first example of using nucleotide derivatives to inhibit hMTH1, thus demonstrating their potential as antitumor agents. New inhibitors: We synthesized triphosphate 8-halogenated-7-deazadG derivatives and showed their inhibitory effects on the human 8-oxo-2′-deoxyguanosine triphosphatase, hMTH1. These triphosphates are poor substrates for hMTH1, but exhibit strong competitive inhibition against hMTH1 at nanomolar levels. Therefore, they are candidates as novel antitumor agents.
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Molecular Biology
- Organic Chemistry